Literature DB >> 33456901

Non-inferiority statistics and equivalence studies.

J Walker1.   

Abstract

Year:  2019        PMID： 33456901      PMCID： PMC7808096          DOI： 10.1016/j.bjae.2019.03.004

Source DB:  PubMed          Journal:  BJA Educ        ISSN： 2058-5349


× No keyword cloud information.
  6 in total

1.  Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.

Authors:  Ralph B D'Agostino; Joseph M Massaro; Lisa M Sullivan
Journal:  Stat Med       Date:  2003-01-30       Impact factor: 2.373

2.  Bio-creep in non-inferiority clinical trials.

Authors:  Siobhan Everson-Stewart; Scott S Emerson
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

3.  Practical guide to sample size calculations: non-inferiority and equivalence trials.

Authors:  Laura Flight; Steven A Julious
Journal:  Pharm Stat       Date:  2015-11-25       Impact factor: 1.894

4.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Douglas G Altman; Stuart J Pocock; Stephen J W Evans
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

5.  How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research.

Authors:  Soyeon Ahn; Seong Ho Park; Kyoung Ho Lee
Journal:  Radiology       Date:  2013-05       Impact factor: 11.105

Review 6.  Through the looking glass: understanding non-inferiority.

Authors:  Jennifer Schumi; Janet T Wittes
Journal:  Trials       Date:  2011-05-03       Impact factor: 2.279
  6 in total
  1 in total

1.  Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.

Authors:  Aikaterini K Seliniotaki; Anna-Bettina Haidich; Maria Lithoxopoulou; Helen Gika; Eleftheria Boutou; Christina Virgiliou; Martha Nikolaidou; Aristides Dokoumetzidis; Nikolaos Raikos; Elisavet Diamanti; Nikolaos Ziakas; Asimina Mataftsi
Journal:  Trials       Date:  2022-04-15       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.